Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Change in Inventory (2023 - 2025)

Historic Change in Inventory for Phathom Pharmaceuticals (PHAT) over the last 3 years, with Q3 2025 value amounting to -$395000.0.

  • Phathom Pharmaceuticals' Change in Inventory fell 19449.76% to -$395000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year increase of 9560.47%. This contributed to the annual value of $6.1 million for FY2024, which is 3495.02% down from last year.
  • Phathom Pharmaceuticals' Change in Inventory amounted to -$395000.0 in Q3 2025, which was down 19449.76% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Phathom Pharmaceuticals' Change in Inventory registered a high of $12.3 million during Q1 2025, and its lowest value of -$395000.0 during Q3 2025.
  • Moreover, its 3-year median value for Change in Inventory was $418000.0 (2024), whereas its average is $3.3 million.
  • Within the past 5 years, the most significant YoY rise in Phathom Pharmaceuticals' Change in Inventory was 286346.15% (2025), while the steepest drop was 19449.76% (2025).
  • Quarter analysis of 3 years shows Phathom Pharmaceuticals' Change in Inventory stood at $9.3 million in 2023, then crashed by 40.24% to $5.6 million in 2024, then tumbled by 107.08% to -$395000.0 in 2025.
  • Its last three reported values are -$395000.0 in Q3 2025, $1.8 million for Q2 2025, and $12.3 million during Q1 2025.